George B. Craig, Jr. Memorial Lecture: “Kill the Messenger: Developing mosquitocidal vaccines and drugs to control mosquito-borne diseases”

Dr. Brian Foy ’94 has helped pioneer studies designed to target mosquito vectors through their bloodmeals as a way to disrupt mosquito-borne pathogen transmission and reduce disease. His work in this field started in graduate school with attempts to develop mosquitocidal vaccine antigen candidates against malaria vectors, and evolved into researching how endectocidal drugs may be used to control the spread of malaria and certain arboviral diseases. His lab’s research spans from molecular and genetic studies to field studies in West Africa and the western United States. His endectocide studies have culminated in leading the first randomized cluster clinical trial testing of ivermectin for malaria control, and he is presently leading a follow-up clinical trial in Burkina Faso. This event was recorded on Thursday, October 28, 2021.

Brian Foy, Ph.D., professor, College of Veterinary Medicine and Biomedical Sciences, Center for Vector-Borne Infectious Diseases, Colorado State University

For more information visit the event website.

Global AffairsHealth and SocietyScience and TechnologyBrian FoyDigest187Eck Institute for Global HealthGlobal HealthMosquito-borne diseaseND ResearchResearchUniversity of Notre Dame

Stay In Touch

Subscribe to our Newsletter

To receive the latest and featured content published to ThinkND, please provide your name and email. Free and open to all.

What interests you?
Select your topics, and we'll curate relevant updates for your inbox.